首頁 > 市場調查報告書 > 醫療設備

生技設備

市場調查報告書

商品編碼

1760539

2025年癌症基因體學及分析全球市場報告

Genomic Cancer Panel And Profiling Global Market Report 2025

出版日期: 2025年07月01日 | 出版商:

The Business Research Company | 英文 175 Pages | 商品交期: 2-10個工作天內

價格

簡介目錄

預計未來幾年，基因組癌症檢測組和分析市場規模將強勁成長。預計到 2029 年，該市場規模將達到 143.7 億美元，複合年成長率為 8.7%。預測期內的成長動力包括液態切片的應用範圍不斷擴大、早期檢測的使用日益增多、客製化療法的持續成長以及伴隨診斷核准數量的增加。預測期內的主要趨勢包括整合人工智慧和機器學習用於基因組數據解釋、多體學方法的開發、雲端基礎的基因組數據儲存和分析、與電子健康記錄的整合以及次世代定序儀(NGS) 平台的擴展。

癌症發生率的上升預計將推動基因組癌症檢測組和分析市場的成長。癌症是一種以體內異常細胞不受控制地增生和擴散為特徵的疾病。癌症發生率的上升主要是由於老化等因素，隨著人們壽命的延長，老化會增加罹患癌症的風險。基因組癌症檢測組和分析用於識別基因突變和生物標記物，以促進個人化治療計劃並改善早期發現和疾病監測。例如，2024 年 1 月，美國癌症協會報告稱，2022 年全球約有 2,000 萬新診斷出癌症病例，970 萬人死亡。隨著人口的成長，預計到 2050 年全球癌症患者人數將增加至 3,500 萬人。因此，癌症發生率的上升可能會推動基因組癌症檢測組和分析市場的成長。

癌症基因組學檢測組和分析市場的主要企業正專注於次世代定序儀等技術創新，以提高癌症診斷的準確性、速度和全面性。次世代定序儀是一種先進的DNA序列測定技術，能夠快速、高通量地分析遺傳物質，以識別基因突變和其他基因組特徵。例如，2025年4月，荷蘭生技公司QIAGEN NV推出了專為次世代定序儀設計的QIAseq檢測組。這些檢測組透過分析700多個基因，實現全面的基因組分析，旨在用於研究和臨床應用，以改善癌症的診斷和治療策略。

全球基因組癌症小組和分析 PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素和限制因素）
最終用途產業分析
全球基因組癌症面板和分析市場：成長率分析
全球基因組癌症檢測組合與分析市場表現：規模與成長，2019-2024 年
全球基因組癌症面板和分析市場預測：規模與成長，2024-2029 年，2034 年
全球基因組癌症面板和分析總目標市場（TAM）

第6章市場區隔

全球基因組癌症檢測組合及分析市場（依組織檢測、績效及預測）2019-2024、2024-2029、2034
固態組織檢查
液體組織檢測
全球基因組癌症面板和分析市場（按技術、性能和預測），2019-2024 年、2024-2029 年、2034 年
次世代定序（NGS）
聚合酵素鏈鎖反應（PCR）
螢光原位雜合技術（FISH）
免疫組織化學（IHC）
其他技術
全球基因組癌症面板和分析市場（按癌症面板類型、表現和預測），2019-2024 年、2024-2029 年、2034 年
單基因面板
多基因面板
全球基因組癌症面板和分析市場的應用、性能和預測，2019-2024 年、2024-2029 年、2034 年
臨床
研究
全球基因組癌症面板和分析市場（按最終用戶、績效和預測）2019-2024 年、2024-2029 年、2034 年
醫院
研究和學術機構
臨床和診斷實驗室
其他最終用戶
全球基因組癌症面板及分析市場，依固態組織檢驗類型細分，績效及預測，2019-2024 年、2024-2029 年、2034 年
切片檢查樣本
手術切除樣本
福馬林固定石蠟包埋（FFPE）組織
新鮮冷凍組織
全球基因組癌症檢測組合及分析市場，依液體組織檢測類型細分，績效及預測，2019-2024 年、2024-2029 年、2034 年
血
尿
唾液
腦脊髓液（CSF）
其他體液

第7章區域和國家分析

基因組癌症面板與分析市場：全球、各地區、績效及預測，2019-2024 年、2024-2029 年、2034 年
全球基因組癌症面板和分析市場（按國家/地區、績效和預測）2019-2024 年、2024-2029 年、2034 年

第8章亞太市場

第9章：中國市場

第10章印度市場

第11章日本市場

第12章澳洲市場

第13章印尼市場

第14章韓國市場

第15章西歐市場

第16章英國市場

第17章德國市場

第18章法國市場

第19章：義大利市場

第20章：西班牙市場

第21章東歐市場

第22章俄羅斯市場

第23章北美市場

第24章美國市場

第25章：加拿大市場

第26章南美洲市場

第27章：巴西市場

第28章中東市場

第29章：非洲市場

第30章競爭格局與公司概況

基因組癌症面板和分析市場：競爭格局
基因組癌症檢測與分析市場：公司簡介
- Hoffmann-La Roche Ltd Overview, Products and Services, Strategy and Financial Analysis
- Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
- Agilent Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
- Hologic Inc. Overview, Products and Services, Strategy and Financial Analysis
- Illumina Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章其他大型創新企業

Sysmex Corporation
QIAGEN NV
Exact Sciences Corporation
ARUP Laboratories
Tempus Labs
Genscript Biotech Corporation
NeoGenomics Inc.
Foundation Medicine
Invitae Corporation
Guardant Health Inc.
Caris Life Sciences
Fulgent Genetics
NanoString Technologies Inc.
Genecast Biotechnology Co. Ltd
Burning Rock DX

第 32 章全球市場競爭基準化分析與儀表板

第33章重大併購

第34章近期市場趨勢

第 35 章高市場潛力國家、細分市場與策略

2029 年癌症基因體學及分析市場：提供新機會的國家
2029 年癌症基因組學面板和分析市場：細分市場帶來新機會
2029 年癌症基因體學檢測及分析市場：成長策略
- 基於市場趨勢的策略
- 競爭對手的策略

第36章附錄

簡介目錄

Product Code: r35416

Genomic cancer panel and profiling is a molecular diagnostic technique that simultaneously analyzes multiple genes to detect genetic mutations, alterations, or biomarkers linked to cancer. Its primary purpose is to guide personalized treatment decisions, predict disease progression, and enhance cancer diagnosis and monitoring.

The main tissue testing types in the genomic cancer panel and profiling market are solid tissue testing and liquid tissue testing. Solid tissue testing involves analyzing samples from solid tumors or organs to identify genetic mutations, biomarkers, or disease characteristics. Various technologies are employed in this process, including next-generation sequencing (NGS), polymerase chain reaction (PCR), fluorescence in-situ hybridization (FISH), immunohistochemistry (IHC), and others. Cancer panels used in this testing include both single-gene and multi-gene panels. These tests are applied in clinical and research settings, serving end users such as hospitals, research and academic institutes, clinical and diagnostic laboratories, among others.

The genomic cancer panel and profiling market research report is one of a series of new reports from The Business Research Company that provides genomic cancer panel and profiling market statistics, including the genomic cancer panel and profiling industry global market size, regional shares, competitors with the genomic cancer panel and profiling market share, detailed genomic cancer panel and profiling market segments, market trends, and opportunities, and any further data you may need to thrive in the genomic cancer panel and profiling industry. This genomic cancer panel and profiling market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The genomic cancer panel and profiling market size has grown strongly in recent years. It will grow from $9.47 billion in 2024 to $10.31 billion in 2025 at a compound annual growth rate (CAGR) of 8.9%. Growth during the historic period can be attributed to the rising global cancer burden, increased use in clinical trials, expansion of diagnostic infrastructure, growing awareness of genetic testing, and increased government and research funding.

The genomic cancer panel and profiling market size is expected to see strong growth in the next few years. It will grow to $14.37 billion in 2029 at a compound annual growth rate (CAGR) of 8.7%. Growth in the forecast period is expected to be driven by the expansion of liquid biopsy applications, growing use in early detection, the continued growth in tailored therapies, and an increase in companion diagnostics approvals. Key trends in the forecast period include the integration of AI and machine learning for genomic data interpretation, the development of multi-omics approaches, cloud-based genomic data storage and analysis, integration with electronic health records, and the expansion of next-generation sequencing (NGS) platforms.

The increasing incidence of cancer is expected to drive the growth of the genomic cancer panel and profiling market. Cancer is a disease characterized by the uncontrolled growth and spread of abnormal cells in the body. The rising cancer incidence is primarily due to factors such as an aging population, which increases the risk of cancer as people live longer. Genomic cancer panels and profiling are used to identify genetic mutations and biomarkers, facilitating personalized treatment plans and improving early detection and disease monitoring. For example, in January 2024, the American Cancer Society reported that approximately 20 million new cancer cases were diagnosed globally in 2022, resulting in 9.7 million deaths. With population growth, the global cancer burden is projected to rise to 35 million cases by 2050. Therefore, the increasing incidence of cancer will drive the growth of the genomic cancer panel and profiling market.

Major companies in the genomic cancer panel and profiling market are focusing on technological innovations, such as next-generation sequencers, which enhance the accuracy, speed, and comprehensiveness of cancer diagnostics. Next-generation sequencers are advanced DNA sequencing technologies that allow for rapid, high-throughput analysis of genetic material to identify mutations and other genomic features. For instance, in April 2025, QIAGEN N.V., a Netherlands-based biotechnology company, launched QIAseq panels designed for next-generation sequencers. These panels enable comprehensive genomic profiling by analyzing over 700 genes, targeting both research and clinical applications to improve cancer diagnostics and treatment strategies.

In June 2023, Quest Diagnostics, a US-based clinical laboratory company, acquired Haystack Oncology, a biotech firm specializing in liquid biopsy technologies for early cancer detection and monitoring. The acquisition expands Quest Diagnostics' capabilities in liquid biopsy and cancer detection, enhancing its genomic testing offerings.

Major players in the genomic cancer panel and profiling market are Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., Agilent Technologies Inc., Hologic Inc., Illumina Inc., Sysmex Corporation, QIAGEN N.V., Exact Sciences Corporation, ARUP Laboratories, Tempus Labs, Genscript Biotech Corporation, NeoGenomics Inc., Foundation Medicine, Invitae Corporation, Guardant Health Inc., Caris Life Sciences, Fulgent Genetics, NanoString Technologies Inc., Genecast Biotechnology Co. Ltd, Burning Rock DX, HTG Molecular Diagnostics Inc., and Predictive Oncology Inc.

North America was the largest region in the genomic cancer panel and profiling market in 2024. The regions covered in genomic cancer panel and profiling report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the genomic cancer panel and profiling market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The genomic cancer panel and profiling market consists of revenues earned by entities by providing services such as genetic mutation analysis, companion diagnostic testing, cancer risk assessment, and screening. The market value includes the value of related goods sold by the service provider or included within the service offering. The genomic cancer panel and profiling market also includes sales of targeted gene panels, companion diagnostic kits, sequencing platforms and instruments, bioinformatics software, and analysis tools. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Genomic Cancer Panel And Profiling Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on genomic cancer panel and profiling market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for genomic cancer panel and profiling ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The genomic cancer panel and profiling market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Tissue Testing: Solid Tissue Testing; Liquid Tissue Testing
2) By Technology: Next-Generation Sequencing (NGS); Polymerase Chain Reaction (PCR); Fluorescence In-Situ Hybridization (FISH); Immunohistochemistry (IHC); Other Technologies
3) By Cancer Panel Type: Single-Gene Panel; Multi-Gene Panel
4) By Application: Clinical; Research
5) By End User: Hospitals; Research And Academic Institutes; Clinical And Diagnostic Laboratories; Other End Users
Subsegments:
1) By Solid Tissue Testing: Biopsy Samples; Surgical Resection Samples; Formalin-Fixed Paraffin-Embedded (FFPE) Tissues; Fresh Frozen Tissues
2) By Liquid Tissue Testing: Blood; Urine; Saliva; Cerebrospinal Fluid (CSF); Other Bodily Fluids
Companies Mentioned: Hoffmann-La Roche Ltd; Thermo Fisher Scientific Inc.; Agilent Technologies Inc.; Hologic Inc.; Illumina Inc.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.

1. Executive Summary

2. Genomic Cancer Panel And Profiling Market Characteristics

3. Genomic Cancer Panel And Profiling Market Trends And Strategies

4. Genomic Cancer Panel And Profiling Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Genomic Cancer Panel And Profiling Growth Analysis And Strategic Analysis Framework

5.1. Global Genomic Cancer Panel And Profiling PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Genomic Cancer Panel And Profiling Market Growth Rate Analysis
5.4. Global Genomic Cancer Panel And Profiling Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Genomic Cancer Panel And Profiling Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Genomic Cancer Panel And Profiling Total Addressable Market (TAM)

6. Genomic Cancer Panel And Profiling Market Segmentation

6.1. Global Genomic Cancer Panel And Profiling Market, Segmentation By Tissue Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Solid Tissue Testing
Liquid Tissue Testing
6.2. Global Genomic Cancer Panel And Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Next-Generation Sequencing (NGS)
Polymerase Chain Reaction (PCR)
Fluorescence In-Situ Hybridization (FISH)
Immunohistochemistry (IHC)
Other Technologies
6.3. Global Genomic Cancer Panel And Profiling Market, Segmentation By Cancer Panel Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Single-Gene Panel
Multi-Gene Panel
6.4. Global Genomic Cancer Panel And Profiling Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Clinical
Research
6.5. Global Genomic Cancer Panel And Profiling Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals
Research And Academic Institutes
Clinical And Diagnostic Laboratories
Other End Users
6.6. Global Genomic Cancer Panel And Profiling Market, Sub-Segmentation Of Solid Tissue Testing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Biopsy Samples
Surgical Resection Samples
Formalin-Fixed Paraffin-Embedded (FFPE) Tissues
Fresh Frozen Tissues
6.7. Global Genomic Cancer Panel And Profiling Market, Sub-Segmentation Of Liquid Tissue Testing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Blood
Urine
Saliva
Cerebrospinal Fluid (CSF)
Other Bodily Fluids

7. Genomic Cancer Panel And Profiling Market Regional And Country Analysis

7.1. Global Genomic Cancer Panel And Profiling Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Genomic Cancer Panel And Profiling Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Genomic Cancer Panel And Profiling Market

8.1. Asia-Pacific Genomic Cancer Panel And Profiling Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Genomic Cancer Panel And Profiling Market, Segmentation By Tissue Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Genomic Cancer Panel And Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Genomic Cancer Panel And Profiling Market, Segmentation By Cancer Panel Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Genomic Cancer Panel And Profiling Market

9.1. China Genomic Cancer Panel And Profiling Market Overview
9.2. China Genomic Cancer Panel And Profiling Market, Segmentation By Tissue Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Genomic Cancer Panel And Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Genomic Cancer Panel And Profiling Market, Segmentation By Cancer Panel Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Genomic Cancer Panel And Profiling Market

10.1. India Genomic Cancer Panel And Profiling Market, Segmentation By Tissue Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Genomic Cancer Panel And Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Genomic Cancer Panel And Profiling Market, Segmentation By Cancer Panel Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Genomic Cancer Panel And Profiling Market

11.1. Japan Genomic Cancer Panel And Profiling Market Overview
11.2. Japan Genomic Cancer Panel And Profiling Market, Segmentation By Tissue Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Genomic Cancer Panel And Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Genomic Cancer Panel And Profiling Market, Segmentation By Cancer Panel Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Genomic Cancer Panel And Profiling Market

12.1. Australia Genomic Cancer Panel And Profiling Market, Segmentation By Tissue Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Genomic Cancer Panel And Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Genomic Cancer Panel And Profiling Market, Segmentation By Cancer Panel Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Genomic Cancer Panel And Profiling Market

13.1. Indonesia Genomic Cancer Panel And Profiling Market, Segmentation By Tissue Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Genomic Cancer Panel And Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Genomic Cancer Panel And Profiling Market, Segmentation By Cancer Panel Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Genomic Cancer Panel And Profiling Market

14.1. South Korea Genomic Cancer Panel And Profiling Market Overview
14.2. South Korea Genomic Cancer Panel And Profiling Market, Segmentation By Tissue Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Genomic Cancer Panel And Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Genomic Cancer Panel And Profiling Market, Segmentation By Cancer Panel Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Genomic Cancer Panel And Profiling Market

15.1. Western Europe Genomic Cancer Panel And Profiling Market Overview
15.2. Western Europe Genomic Cancer Panel And Profiling Market, Segmentation By Tissue Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Genomic Cancer Panel And Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Genomic Cancer Panel And Profiling Market, Segmentation By Cancer Panel Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Genomic Cancer Panel And Profiling Market

16.1. UK Genomic Cancer Panel And Profiling Market, Segmentation By Tissue Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Genomic Cancer Panel And Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Genomic Cancer Panel And Profiling Market, Segmentation By Cancer Panel Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Genomic Cancer Panel And Profiling Market

17.1. Germany Genomic Cancer Panel And Profiling Market, Segmentation By Tissue Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Genomic Cancer Panel And Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Genomic Cancer Panel And Profiling Market, Segmentation By Cancer Panel Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Genomic Cancer Panel And Profiling Market

18.1. France Genomic Cancer Panel And Profiling Market, Segmentation By Tissue Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Genomic Cancer Panel And Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Genomic Cancer Panel And Profiling Market, Segmentation By Cancer Panel Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Genomic Cancer Panel And Profiling Market

19.1. Italy Genomic Cancer Panel And Profiling Market, Segmentation By Tissue Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Genomic Cancer Panel And Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Genomic Cancer Panel And Profiling Market, Segmentation By Cancer Panel Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Genomic Cancer Panel And Profiling Market

20.1. Spain Genomic Cancer Panel And Profiling Market, Segmentation By Tissue Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Genomic Cancer Panel And Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Genomic Cancer Panel And Profiling Market, Segmentation By Cancer Panel Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Genomic Cancer Panel And Profiling Market

21.1. Eastern Europe Genomic Cancer Panel And Profiling Market Overview
21.2. Eastern Europe Genomic Cancer Panel And Profiling Market, Segmentation By Tissue Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Genomic Cancer Panel And Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Genomic Cancer Panel And Profiling Market, Segmentation By Cancer Panel Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Genomic Cancer Panel And Profiling Market

22.1. Russia Genomic Cancer Panel And Profiling Market, Segmentation By Tissue Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Genomic Cancer Panel And Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Genomic Cancer Panel And Profiling Market, Segmentation By Cancer Panel Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Genomic Cancer Panel And Profiling Market

23.1. North America Genomic Cancer Panel And Profiling Market Overview
23.2. North America Genomic Cancer Panel And Profiling Market, Segmentation By Tissue Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Genomic Cancer Panel And Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Genomic Cancer Panel And Profiling Market, Segmentation By Cancer Panel Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Genomic Cancer Panel And Profiling Market

24.1. USA Genomic Cancer Panel And Profiling Market Overview
24.2. USA Genomic Cancer Panel And Profiling Market, Segmentation By Tissue Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Genomic Cancer Panel And Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Genomic Cancer Panel And Profiling Market, Segmentation By Cancer Panel Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Genomic Cancer Panel And Profiling Market

25.1. Canada Genomic Cancer Panel And Profiling Market Overview
25.2. Canada Genomic Cancer Panel And Profiling Market, Segmentation By Tissue Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Genomic Cancer Panel And Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Genomic Cancer Panel And Profiling Market, Segmentation By Cancer Panel Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Genomic Cancer Panel And Profiling Market

26.1. South America Genomic Cancer Panel And Profiling Market Overview
26.2. South America Genomic Cancer Panel And Profiling Market, Segmentation By Tissue Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Genomic Cancer Panel And Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Genomic Cancer Panel And Profiling Market, Segmentation By Cancer Panel Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Genomic Cancer Panel And Profiling Market

27.1. Brazil Genomic Cancer Panel And Profiling Market, Segmentation By Tissue Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Genomic Cancer Panel And Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Genomic Cancer Panel And Profiling Market, Segmentation By Cancer Panel Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Genomic Cancer Panel And Profiling Market

28.1. Middle East Genomic Cancer Panel And Profiling Market Overview
28.2. Middle East Genomic Cancer Panel And Profiling Market, Segmentation By Tissue Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Genomic Cancer Panel And Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Genomic Cancer Panel And Profiling Market, Segmentation By Cancer Panel Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Genomic Cancer Panel And Profiling Market

29.1. Africa Genomic Cancer Panel And Profiling Market Overview
29.2. Africa Genomic Cancer Panel And Profiling Market, Segmentation By Tissue Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Genomic Cancer Panel And Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Genomic Cancer Panel And Profiling Market, Segmentation By Cancer Panel Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Genomic Cancer Panel And Profiling Market Competitive Landscape And Company Profiles

30.1. Genomic Cancer Panel And Profiling Market Competitive Landscape
30.2. Genomic Cancer Panel And Profiling Market Company Profiles
- 30.2.1. Hoffmann-La Roche Ltd Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Agilent Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Hologic Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Illumina Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Genomic Cancer Panel And Profiling Market Other Major And Innovative Companies

31.1. Sysmex Corporation
31.2. QIAGEN N.V.
31.3. Exact Sciences Corporation
31.4. ARUP Laboratories
31.5. Tempus Labs
31.6. Genscript Biotech Corporation
31.7. NeoGenomics Inc.
31.8. Foundation Medicine
31.9. Invitae Corporation
31.10. Guardant Health Inc.
31.11. Caris Life Sciences
31.12. Fulgent Genetics
31.13. NanoString Technologies Inc.
31.14. Genecast Biotechnology Co. Ltd
31.15. Burning Rock DX

32. Global Genomic Cancer Panel And Profiling Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Genomic Cancer Panel And Profiling Market

34. Recent Developments In The Genomic Cancer Panel And Profiling Market

35. Genomic Cancer Panel And Profiling Market High Potential Countries, Segments and Strategies

35.1 Genomic Cancer Panel And Profiling Market In 2029 - Countries Offering Most New Opportunities
35.2 Genomic Cancer Panel And Profiling Market In 2029 - Segments Offering Most New Opportunities
35.3 Genomic Cancer Panel And Profiling Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies